CI in the 13F filings
The Cigna Group · CUSIP 125523100
- Quarter end
- 31 Dec 2024
- the date the book describes
- Filed
- 5 Nov 2026
- latest of these filings; the earliest 11 Feb 2025
- Managers listing it
- 23
- at least, of 95 tracked, among listed positions
- Comparable managers
- 94
- filed both Q3 2024 and Q4 2024; 21 listed it in both
- Shares listed
- 55,097,569
- combined, among listed positions
- Reported value
- $15.2bn
- combined, at the quarter end
Among the 94 comparable managers: 13 buyers (opened or added shares) and 12 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing CI in Q4 2024
23 of 23 holders
Largest increases and reductions, by shares
Increases
- Two Sigma Advisers LPexisting position · 816,200 shares now+600,300
- Voloridge Investment Management LLCexisting position · 643,253 shares now+514,841
- MFS Investment Managementexisting position · 11,556,278 shares now+501,320
- Bridgewater Associates LPexisting position · 579,482 shares now+255,646
- Squarepoint Ops LLCexisting position · 352,216 shares now+239,870
Reductions
- Fidelity (FMR LLC)existing position · 12,465,481 shares now-1,764,916
- T. Rowe Price Associates Incexisting position · 10,962,479 shares now-1,117,751
- Arrowstreet Capital LPexisting position · 1,744,197 shares now-655,969
- Glenview Capital Management LLCexisting position · 632,408 shares now-419,255
- AQR Capital Management LLCexisting position · 996,273 shares now-417,969
New positions and exits
New (1)
Exited (2)
- Hudson Bay Capital Management LPwas $61m
- Caxton Associates LLPwas $1.9m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2018 | 33 | $20.6bn | n.a. | n.a. |
| Q1 2019 | 27 | $18.1bn | n.a. | n.a. |
| Q2 2019 | 26 | $17.5bn | n.a. | n.a. |
| Q3 2019 | 27 | $16.6bn | n.a. | n.a. |
| Q4 2019 | 28 | $23.1bn | n.a. | n.a. |
| Q1 2020 | 26 | $19.8bn | n.a. | n.a. |
| Q2 2020 | 29 | $20.8bn | n.a. | n.a. |
| Q3 2020 | 34 | $18.1bn | n.a. | n.a. |
| Q4 2020 | 22 | $21.9bn | n.a. | n.a. |
| Q1 2021 | 24 | $23.9bn | n.a. | n.a. |
| Q2 2021 | 31 | $22.5bn | n.a. | n.a. |
| Q3 2021 | 30 | $17.8bn | n.a. | n.a. |
| Q4 2021 | 26 | $20.1bn | n.a. | n.a. |
| Q1 2022 | 28 | $20.4bn | n.a. | n.a. |
| Q2 2022 | 32 | $22.1bn | n.a. | n.a. |
| Q3 2022 | 31 | $21.5bn | n.a. | n.a. |
| Q4 2022 | 30 | $24.7bn | n.a. | n.a. |
| Q1 2023 | 35 | $18.2bn | n.a. | n.a. |
| Q2 2023 | 30 | $19.8bn | n.a. | n.a. |
| Q3 2023 | 28 | $19.8bn | n.a. | n.a. |
| Q4 2023 | 31 | $20.6bn | 16 | 19 |
| Q1 2024 | 28 | $24.0bn | 14 | 17 |
| Q2 2024 | 28 | $19.5bn | 15 | 15 |
| Q3 2024 | 25 | $20.2bn | 13 | 14 |
| Q4 2024 | 23 | $15.2bn | 13 | 12 |
| Q1 2025 | 24 | $18.4bn | 15 | 10 |
| Q2 2025 | 34 | $19.5bn | 24 | 10 |
| Q3 2025 | 28 | $16.2bn | 14 | 15 |
| Q4 2025 | 21 | $14.6bn | 20 | 23 |
| Q1 2026 | 26 | $13.5bn | 19 | 20 |
| Q2 2026 | 28 | $13.0bn | 22 | 19 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
CI and UNH →CI and ELV →CI and HUM →Choose a stock to compare with CI →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own CI, latest filings →Back to the 13F Explorer →